ACE2 and COVID-19: In addition, pancreatic damage has been reported to occur in patients with severe COVID-19, suggesting that SARS-CoV-2 may bind to ACE2 in the pancreas and directly damage the islets, worsening glycemic control in COVID-19 patients (Liu et al., 2020).